Roma AI Raises $1.2M Seed Round

TWi Biotechnology, Inc.

TWi Biotechnology(6610.TWO) is a late stage clinical biopharmaceutical company developing innovative therapies for rare dermatologic diseases and central nervous system (CNS) disorders. With established expertise in 505(b)(2) development, the company focuses on advancing differentiated formulations that address significant unmet medical needs using clinically validated mechanisms. Our approach is to efficiently transform proven pharmacology into value-enhanced, first-in-class therapies with optimized delivery, safety, and patient experience. By leveraging existing human data, we aim to reduce development time, cost, and clinical risk while delivering meaningful innovation to underserved patient populations. Our management team brings extensive experience across clinical development, regulatory strategy, and commercialization, having held leadership roles in global pharmaceutical and biotechnology organizations. This collective expertise supports disciplined and capital-efficient advancement of our pipeline. AC203, our lead program for rare dermatologic indications, has received U.S. FDA Orphan Drug Designation (ODD), underscoring its therapeutic potential and regulatory advantage. In parallel, we are advancing CNS programs targeting major psychiatric conditions, including areas of overlap with women’s health, further strengthening a balanced pipeline across rare and high-prevalence diseases. TWi Biotechnology combines clear therapeutic focus, proven development efficiency, and experienced leadership to advance impactful, patient-centered therapies in rare dermatologic diseases, with emerging expansion into women’s health.

Maglut Heavy Industries

Maglut Heavy Industries | 241 followers on LinkedIn. We’re rebuilding America’s rare earth engine.

Nanolope

Nanolope is a Berlin‑based deep‑tech company developing high‑density thermal energy storage materials for buildings and energy systems. The technology increases the thermal mass of rooms, reduces overheating, and enables passive temperature stabilization without additional HVAC infrastructure. Nanolope focus on scalable, long‑lasting and fully recyclable PCM‑based materials that outperform conventional building components in energy efficiency and comfort, and collaborates with leading research institutes and industry partners to bring advanced thermal storage into real‑world applications across construction, energy and cooling. The company has been recognized with multiple innovation awards, including the Hugo Junkers Award, IQ Innovationspreis, Science4Life Energy Cup and Energy Start Up Award 2026 by dena. The first customers are larger real estate enterprises, such as LEG, Metzger and Nanz. Contact: info@nanolope.de